On 8 September 2025, the European Commission adopted a delegated regulation amending Annex I of Regulation (EU) 2021/821 on dual-use items. This revision adds, for the first time, quantum computers as well as several associated components and equipment to the European export control list. Those affected notably include certain cryogenic cooling systems, parametric amplifiers, and cryogenic wafer-testing equipment.
Delegated Regulation (EU) 2025/2003, published on 14 November 2025, entered into force on 15 November 2025.
This regulation is not the first applicable in France on these technologies. Under a decree (arrĂȘtĂ©) of 2 February 2024, amended on 27 March 2025, France already maintained a national list controlling certain quantum computers, components, and enabling technologies. This decree was signed for repeal on 10 March 2026 and published on 26 April 2026, with the French list ceasing to apply as of 27 April 2026 in favor of the common European regime, the items concerned now being covered by list (EU) 2025/2003. The signal is therefore not limited to the entry into force of 15 November 2025: it also encompasses this shift from national control to a harmonized regime applicable across the twenty-seven member states.
Why this signal is strong. This listing does not result from the traditional multilateral process. Since 2022, tensions within the Wassenaar Arrangement have prevented consensus on certain controls targeting advanced technologies. Several partners therefore coordinated their regimes outside this framework, ahead of their integration into national or regional legal regimes. The European Union thus established a common list applicable across its twenty-seven member states, in the process resolving the fragmentation previously documented by the existence of separate national lists, including France's 2024 list.
What this signal reveals. Quantum dependency is not solely material, technological, and capital-based. It is also regulatory. Access to quantum computers, to certain components, and to the equipment essential to their manufacture now depends on authorization regimes that can vary by jurisdiction. The United States applies its own parallel framework, notably through ECCN categories 3A901, 3A904, and 4A906. Despite coordination among partners, differences in scope, technical thresholds, and procedures can complicate lawful technology transfers and increase compliance costs for manufacturers, laboratories, and their suppliers.